Bristol-Myers Squibb Co. (BMY) PT Lowered to $68 at Leerink Partners
Leerink Partners analyst David Risinger ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
